ROBERTS 063 Pill - white capsule/oblong, 14mm
Generic Name: anagrelide
Pill with imprint ROBERTS 063 is White, Capsule/Oblong and has been identified as Agrylin 0.5 mg. It is supplied by Shire US Inc.
Agrylin is used in the treatment of Thrombocythemia and belongs to the drug class miscellaneous coagulation modifiers. Risk cannot be ruled out during pregnancy. Agrylin 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ROBERTS 063
Agrylin
- Generic Name
- anagrelide
- Imprint
- ROBERTS 063
- Strength
- 0.5 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous coagulation modifiers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Shire US Inc
- National Drug Code (NDC)
- 54092-0063
See also:
PegIntron
PegIntron is used to treat chronic hepatitis C in adults. Learn about side effects, interactions ...
Sylatron
Sylatron (peginterferon alfa-2b) used to prevent malignant melanoma from coming back after it has ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Advate
Advate (antihemophilic factor) is used to prevent bleeding episodes in adults and children with ...
Adzynma
Adzynma (ADAMTS13, recombinant-krhn) is a human recombinant protein that may be used to prevent or ...
Alhemo
Alhemo is used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in ...
Alphanine SD
Alphanine SD is used for factor ix deficiency, hemophilia b
More about Agrylin (anagrelide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.